This animation is provided for general information only. It is not intended to provide clinical instructions for use (IFU). Always read and understand the IFU supplied with the device prior to use.

PRESS RELEASEs

Intact Vascular Announces Enrollment of First European Patient in Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial with the Tack Endovascular System®

July 18, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized

FDA Approves 6-Month Primary Endpoint for the Tack Endovascular System® in Below the Knee Disease

July 10, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to …

Intact Vascular Adds Howard Rosen to its Executive Management Team as VP Marketing and Business Development

May 1, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Howard Rosen has joined its executive management team as Vice President of Marketing and Business Development.  In …

Intact Vascular Announces Completion of Enrollment in the Tack Optimized Balloon Angioplasty II (TOBA II) Clinical Trial

March 23, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized …

Intact Vascular’s Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

February 13, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized …

Intact Vascular’s Tack Endovascular System® Secures CE Mark for Repair of Dissections Following Angioplasty Below the Knee

January 17, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it has attained the CE (Conformité Européenne) Mark for the Tack Endovascular System to repair arterial dissections fo…